CAT and diabetes mellitus: Administration of agmatine to animals with DM significantly increased SOD (Figure 4A), CAT (Figure 4B), GPx and GR (Figure 4C) activities 2.27-fold, 1.3-fold, 43 % and 72 %, respectively, in comparison to the non-treated diabetes group.